SPECIALITY MEDICINES LIMITED

About

Speciality Medicines Limited engages in the manufacturing, marketing and distribution of finished formulations of specialty pharmaceutical products in India and internationally. The company offers tablets, capsules, cream, syrups, eye drops, gel, infusion, inhalation, inhaler, injection, nasal spray, ointment, ophthalmic, oral solution, oral suspension, sachet, and suspension for oncology, immunology, neurology, and rare diseases therapeutic areas. It also provides patient, hospitals, institutions and NGO supplies, validated controlled supply management, the authenticity of the product by providing documents, warehousing facility, and tracking delivery services. In addition, the company engages in the contract manufacturing business. The company was incorporated in 2021 and is based in Mumbai, India.

Quarterly Results

No quarterly results synced yet for this stock.

Data is backfilled from screener.in — check back soon.

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Sales	75.00	58.00	28.00	23.00	40.00
Expenses	62.00	49.00	22.00	20.00	38.00
Operating Profit	14.00	9.00	5.00	4.00	2.00
OPM %	18.00	16.00	19.00	15.00	6.00
Other Income	1.00	0.00	0.00	0.00	0.00
Interest	1.00	1.00	1.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00
Profit before tax	13.00	9.00	5.00	3.00	2.00
Tax %	0.00	1.00	36.00	43.00	31.00
Net Profit	13.00	9.00	3.00	2.00	1.00
EPS in Rs	14.83	13.38	5.73	4.42	70.48
Dividend Payout %	0.00	0.00	0.00	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Equity Capital	9.00	6.00	5.00	4.00	0.21
Reserves	62.00	24.00	10.00	2.00	2.00
Borrowings	7.00	5.00	3.00	4.00	1.00
Other Liabilities	17.00	5.00	5.00	4.00	3.00
Total Liabilities	95.00	40.00	23.00	13.00	6.00
Fixed Assets	2.00	2.00	1.00	2.00	2.00
CWIP	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00
Other Assets	93.00	38.00	21.00	11.00	4.00
Total Assets	95.00	40.00	23.00	13.00	6.00

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Cash from Operating Activity	-1.00	-6.00	-5.00	-4.00	1.00
Cash from Investing Activity	-3.00	-2.00	0.00	0.00	-2.00
Cash from Financing Activity	28.00	8.00	5.00	4.00	2.00
Net Cash Flow	24.00	1.00	0.00	0.00	0.00
Free Cash Flow	-1.00	-6.00	-5.00	-4.00	-1.00
CFO/OP %	-9.00	-63.00	-66.00	-101.00	36.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Debtor Days	128.00	60.00	142.00	87.00	23.00
Inventory Days	191.00	150.00	161.00	103.00	5.00
Days Payable	80.00	8.00	48.00	40.00	12.00
Cash Conversion Cycle	239.00	202.00	255.00	149.00	16.00
Working Capital Days	221.00	180.00	185.00	76.00	-3.00
ROCE %	25.00	34.00	38.00	52.00	—